Who Is Responsible for What: Supplier, Purchaser and the Bench

Research material moves through several pairs of hands, and each pair carries a different set of obligations. Most of the confusion in this area comes from assuming that responsibility transfers with the parcel — that whatever the supplier did discharges the purchaser, or that whatever the purchaser agreed to protects the supplier. Neither is how it works.

Three parties, not two

It helps to separate the supplier, the purchasing organisation, and the individual at the bench. They are frequently the same person in a small operation, which is exactly when the distinction is most useful — because the duties remain separate even when the people do not.

The supplier’s obligations run to what it sells and how it describes it. The organisation’s run to authorisation, premises, records and the conditions its people work under. The individual’s run to the actual handling, and to using the material within the terms it arrived under.

What sits with the supplier

• Accurate description. The material is what it is represented to be, and the analytical claims made about it are supported by work actually done — the evidentiary standard set out in how to read a certificate of analysis.
• Not representing the product as a drug. This is the load-bearing obligation in this market. A substance sold or described for use in humans is a drug question under the Food and Drugs Act regardless of what the label says it is for, which is why the framing in the regulatory status of research peptides in Canada is a constraint on the seller rather than a disclaimer.
• Hazard communication where the regime applies. A supplier label and safety data sheet where the product is a hazardous product, per hazardous product classification.
• Correct classification of what it ships, as consignor, under the transport rules in shipping classification and dry ice.
• Traceability. Lot identification connecting the container to the documentation, in the sense of batch and lot numbering.

What sits with the purchasing organisation

• Authorisation for the work itself. Whatever approvals the research requires — institutional, ethical, regulatory — are obtained by the people doing it. No supply arrangement provides them and no supplier can.
• Suitability of the premises and the people. Facilities appropriate to the material, and staff who have been trained, which is a duty that survives the material being unclassified.
• Verifying its own legal position. Including checking the compound against the Controlled Drugs and Substances Act schedules directly, as set out in the regulatory status of research peptides in Canada, done against the primary source rather than taken from the seller.
• Storage, security and disposal under its own arrangements and local requirements, per disposing of research peptides.
• Records. What was bought, when, from whom, what happened to it, in the form described in inventory labels and records.

What sits with the person at the bench

Using the material within the terms it was supplied under, handling it according to local procedure, labelling what they decant, and recording what they did with it. This is where the terms of supply stop being paperwork and become a constraint on conduct.

It is also where the limits of a certificate become practical. A document describes the lot as it was assessed; what happened to the vial afterwards is entirely in the hands of whoever has held it since, which is the point made in what one certificate cannot tell you.

The handover, and what it does not transfer

Title and physical risk pass on delivery. Regulatory responsibility does not work that way — it is not a single quantity that moves from one party to another, but a set of separate duties that each party holds independently and simultaneously.

Two consequences follow. A supplier does not discharge its obligations because a purchaser agreed to terms; describing a product for human use is not cured by a purchaser’s acknowledgement that it is for research. And a purchaser does not acquire the supplier’s compliance by buying from it; a well-documented supplier does not authorise the buyer’s work. The duties are held in parallel, not handed over.

Where the terms of supply genuinely matter

Research-use-only terms are sometimes read as legal decoration. They are more useful read as a statement of what the material was supplied for, which defines the scope the purchaser has undertaken to stay within and is therefore the reference point if anything is ever questioned.

They are also a limit on the supplier. A seller who supplies on research terms and then describes the product in terms of human effect has contradicted its own basis of supply, and the description governs over the label — which is why the absence of use guidance across this site is deliberate rather than an omission.

The short version

The supplier is answerable for what it sells and how it describes it. The purchaser is answerable for whether they may lawfully do the work, and for everything that happens to the material after it arrives. Neither position is improved by the other party having done its job well.

None of the above is legal advice, and the statutes and regulations referred to across these notes — published in consolidated form by the Department of Justice — are the authority. Anyone whose position turns on a specific question should work from those texts or take proper advice.